home / news releases


Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

Now Trending

Company Name:Air Lease Corporation Class A
Stock Symbol:AL
Market:NYSE
Website:airleasecorp.com

Menu

AL AL Quote AL Short AL News AL Articles AL Message Board
Get Alerts

News, Short Squeeze, Breakout and More Instantly...

Search News Releases

OPRA - Opera Ltd (OPRA) announced stock dividend $0.39 on Ex-Date July 02, 2024

2024-07-01 09:00:22 ET Opera Ltd (OPRA) declaring a stock dividend of $0.39 per share on Ex-Date : July 02, 2024. Shareholders on record as of July 02, 2024 are eligible for the dividend. The payment date is scheduled for July 15, 2024, and the declaration was officially made on Jun...

OBT - Orange Bank & Trust Company Announces Retirement of Executive Vice President, Michael Coulter, as Chief Lending Officer

He will remain with the bank, in a part time position, as Strategic Lending Relationship Officer EVP Deputy Chief Lending Officer, Greg Sousa to assume CLO role MIDDLETOWN, NY / ACCESSWIRE / July 1, 2024 / Orange Bank & Trust Company announced today that Michael Coulter will retire...

LBPH - Longboard Pharmaceuticals Receives Breakthrough Therapy Designation for Bexicaserin (LP352)

U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for bexicaserin for the treatment of seizures associated with Developmental and Epileptic Encephalopathies (DEEs) Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical...

PLTK - Bingo Blitz Champions "Share Your Bingo Moment" Campaign Featuring Gold Medalists Kerri Walsh Jennings, Alex Morgan and Aly Raisman

Bingo Blitz Champions "Share Your Bingo Moment" Campaign Featuring Gold Medalists Kerri Walsh Jennings, Alex Morgan and Aly Raisman PR Newswire HERZLIYA, Israel , July 1, 2024 /PRNewswire/ -- In 25 days the biggest event of the summer kicks off and the countdown ...

PPBT - Purple Biotech Announces Exercise of Warrants for $2 Million Gross Proceeds

REHOVOT, Israel, July 01, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced ...

FAT - Smokey Bones Hosts Giveback Day to Support the Robert Irvine Foundation on July 3

15% of Proceeds to Support Foundation, Plus, Active and Retired Military Personnel Enjoy 20% Off Plantation, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Smokey Bones , owned by FAT (Fresh. Authentic. Tasty.) Brands Inc., continues to join forces with the Robert Irvine Fou...

GNTY - Guaranty Bancshares, Inc. Announces Second Quarter 2024 Earnings Release and Conference Call Schedule

Guaranty Bancshares, Inc. (NYSE: GNTY), the parent company of Guaranty Bank & Trust, N.A. (the "Bank"), announced today that it will hold a conference call to discuss second quarter 2024 financial results on Monday, July 15, 2024 at 10:00 a.m. CT. The related earnings press release will be is...

TURN - 180 Degree Capital Corp. Notes Average Discount of Net Asset Value Per Share to Stock Price for Sixth Month of Initial Measurement Period of Its Discount Management Program

MONTCLAIR, N.J., July 01, 2024 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (“180 Degree Capital”) (NASDAQ: TURN), noted today that the average discount between its estimated daily net asset value per share (“NAV”) and its daily closing stock price during June 2024 and...

DGICB - Donegal Group Inc. Announces Release Date for Second Quarter 2024 Results

MARIETTA, Pa., July 01, 2024 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) announced today that it plans to release its results for second quarter ended June 30, 2024 on Thursday, July 25, 2024, before the opening of regular trading on the NASDAQ Stock Market. The Compa...

TCON - TRACON Pharmaceuticals Announces Termination of ENVASARC Trial and Will Explore Strategic Alternatives Leveraging its In-House Product Development Platform

The objective response rate by blinded independent central review in the fully enrolled ENVASARC pivotal trial in the 82 evaluable patients is 5% (four responders) and did not meet the primary endpoint of 11% Company will focus on exploring strategic alternatives, that may include a var...

Previous 10 Next 10